Olmutinib
- BI 1482694 - HM71224
Axon 4144
CAS:
1353550-13-6
Purity:
99%
- Soluble in DMSO
- MF: C26H26N6O2S
- MW: 486.59
Description
Olmutinib is a third-generation, orally bioavailable and irreversible Tyrosine Kinase Inhibitor, potently and selectively targeting EGFR mutants with Ki values of ~10 nM (in vitro cell assays, against sensitizing (Del19, L858R) and resistance (T790M) EGFR mutations), highly selective over Wt EGFR (Ki = >2000nM, >200-fold selectivity).
More Information
| Parent CAS No. | 1353550-13-6 |
|---|---|
| Chemical Name | N-(3-(2-(4-(4-Methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide |
| extra_info | Sold in collaboration with Chemietek |
| MFCD | N.A. |
| Short Description | EGFR inhibitor |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 3040 | Abivertinib |
From $104.50 |
| 4055 | Limertinib |
From $143.00 |
| 4074 | AZ5104 |
From Inquiry |
| 4130 | PELI1/EGFR disruptor S62 |
From $143.00 |
| 4138 | CUDC-101 |
From Inquiry |
Other Categories
Get a Quote for
Loading...